Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Athena Diagnostics | RCV000517679 | SCV000613617 | benign | not specified | 2017-08-02 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV001111696 | SCV001269272 | uncertain significance | Maturity-onset diabetes of the young type 3 | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases did not allow this variant to be ruled in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. |
Ambry Genetics | RCV002341209 | SCV002640494 | likely benign | Maturity onset diabetes mellitus in young | 2017-09-18 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
KCCC/NGS Laboratory, |
RCV003316663 | SCV004015765 | benign | Nonpapillary renal cell carcinoma | 2023-07-07 | criteria provided, single submitter | clinical testing | |
Ce |
RCV003392347 | SCV004132113 | benign | not provided | 2022-05-01 | criteria provided, single submitter | clinical testing | HNF1A: BS1, BS2 |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000517679 | SCV005394869 | benign | not specified | 2024-09-23 | criteria provided, single submitter | clinical testing | |
Clinical Genomics, |
RCV002341209 | SCV002605534 | likely risk allele | Maturity onset diabetes mellitus in young | flagged submission | research | Mutations in HNF1A gene can predispose to MODY3. It is associated with both micro and macrovascular complications of diabetes, especially cardiovascular complications. Associated with glucosuria. May respond well to sulfonylureas. Sufficient evidence is found to confer the association of this particular variant rs561269721 with MODY3. |